Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Anupam Rasayan India is a custom synthesis and manufacturing (CSM) specialty chemicals company making complex life-science ingredients — mainly agrochemical actives and intermediates, plus pharma and personal care intermediates — under multi-year contracts with global innovators, largely Japanese and European majors. It operates multiple plants in Gujarat and has been adding polymer/other specialty chemistries, with long-term contracts and letters of intent underpinning revenue visibility. Working-capital intensity is a known characteristic of its model.
A leading Indian custom-synthesis partner for global agrochemical innovators.
Anupam Rasayan India Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Anupam Rasayan India Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 15.09 | 8.50 | 11.89 |
| Book value / share (₹) | 406.68 | 280.33 | 266.94 |
| Return on equity | 3.7% | 3.0% | 4.4% |
| Return on capital employed | 7.1% | 8.6% | 9.2% |
| Operating margin | 16.3% | 20.8% | 20.4% |
| Net margin | 9.4% | 11.1% | 11.3% |
| EBITDA | ₹525 Cr | ₹401 Cr | ₹381 Cr |
| Free cash flow | ₹-221 Cr | ₹-440 Cr | ₹-657 Cr |
| Total debt | ₹1,815 Cr | ₹1,318 Cr | ₹1,020 Cr |
| Debt to equity | 0.39 | 0.43 | 0.35 |
| Interest coverage | 2.6 | 2.7 | 3.4 |
| Current ratio | 1.43 | 1.42 | 1.69 |
| Shares outstanding | 11,38,48,000 | 10,99,31,000 | 10,97,85,900 |
Open the full income statement, balance sheet and cash flow for ANURAS →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.